Dr. Kim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Manning Drive
Chapel Hill, NC 27599Phone+1 984-974-0000
Summary
- Dr. Hong Jin Kim is a surgical oncologist in Chapel Hill, NC and is affiliated with multiple hospitals in the area, including UNC REX Health Care, University of North Carolina Hospitals, and Hillsborough Hospital. He received his medical degree from University of Virginia School of Medicine, his residency at the University of Chicago, and his surgical oncology fellowship at Memorial Sloan Kettering Cancer Center, and has been in practice 25 years. He specializes in pancreatic malignancies, colon & rectal surgery, hepatobiliary surgery, soft tissue sarcomas, and surgical oncology (other than breast) and is experienced in biliary tract disease, gastric cancer, pancreatic disease, and soft tissue sarcomas. He is the Vice Chair of Strategy and Outreach in the Department of Surgery, and the Chief of the Division of Surgical Oncology and Endocrine Surgery.
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1999 - 2001
- University of ChicagoResidency, Surgery, 1992 - 1999
- University of Virginia School of MedicineClass of 1992
Certifications & Licensure
- NC State Medical License 2001 - 2025
- NY State Medical License 1999 - 2002
- IL State Medical License 1992 - 1999
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional analysis.Haleh Amirian, Erin Dickey, Ifeanyichukwu Ogobuiro, Edmond W Box, Ankit Shah
Journal of Surgical Oncology. 2024-10-01 - Trends in the use of immunotherapy to treat soft tissue sarcoma.Yoshiko Iwai, Xavier L Baldwin, Timothy Feeney, Chris B Agala, Ted K Yanagihara
American Journal of Surgery. 2024-10-01 - Tumor-intrinsic and Cancer-associated Fibroblast Subtypes Independently Predict Outcomes in Pancreatic Cancer.Jaewon J Lee, Joseph F Kearney, Hannah E Trembath, Arthi Hariharan, Michelle E LaBella
Annals of Surgery. 2024-10-01
Grant Support
- Nf-Kb Targets In The Chemoresistance Of GI MalignanciesNational Cancer Institute2004–2008
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: